SLI
IDXX icon

Sumitomo Life Insurance’s Idexx Laboratories IDXX Stock Holding History

Sumitomo Life Insurance’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$656K Sell
1,246
-34
-3% -$19.1K 0.01% 240
2026
Q1 		$719K Buy
1,280
+41
+3% +$26.3K 0.02% 224
2025
Q4 		$838K Sell
1,239
-2,075
-63% -$1.41M 0.02% 206
2025
Q3 		$2.12M Sell
3,314
-40
-1% -$24.3K 0.07% 115
2025
Q2 		$1.8M Sell
3,354
-85
-2% -$40.6K 0.12% 123
2025
Q1 		$1.44M Buy
3,439
+12
+0.4% +$5.21K 0.05% 146
2024
Q4 		$1.42M Sell
3,427
-1,370
-29% -$601K 0.03% 159
2024
Q3 		$2.42M Buy
4,797
+72
+2% +$35K 0.05% 100
2024
Q2 		$2.3M Buy
4,725
+123
+3% +$61.7K 0.05% 101
2024
Q1 		$2.48M Sell
4,602
-117
-2% -$63.9K 0.06% 95
2023
Q4 		$2.62M Sell
4,719
-158
-3% -$74.2K 0.08% 78
2023
Q3 		$2.13M Buy
4,877
+185
+4% +$92.3K 0.06% 90
2023
Q2 		$2.36M Buy
4,692
+12
+0.3% +$5.75K 0.1% 78
2023
Q1 		$2.34M Sell
4,680
-26
-0.6% -$12.4K 0.2% 75
2022
Q4 		$1.92M Sell
4,706
-74
-2% -$28.7K 0.14% 94
2022
Q3 		$1.56M Sell
4,780
-24
-0.5% -$8.82K 0.07% 114
2022
Q2 		$1.69M Buy
4,804
+65
+1% +$26.5K 0.05% 115
2022
Q1 		$2.59M Sell
4,739
-114
-2% -$60K 0.06% 85
2021
Q4 		$3.2M Buy
4,853
+84
+2% +$52.7K 0.08% 70
2021
Q3 		$2.97M Buy
4,769
+1,304
+38% +$876K 0.08% 71
2021
Q2 		$2.19M Sell
3,465
-683
-16% -$377K 0.07% 105
2021
Q1 		$2.03M Buy
4,148
+603
+17% +$302K 0.08% 124
2020
Q4 		$1.77M Buy
+3,545
New +$1.59M 0.07% 145

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Sumitomo Life Insurance's IDXX Position: Q2 2026 in Review

Sumitomo Life Insurance reduced its Idexx Laboratories (IDXX) stake by 2.7% in Q2 2026, selling an estimated $19.1K and leaving 1,246 shares worth $656K. The position accounts for 0.01% of the portfolio, ranked #240.

Sumitomo Life Insurance first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $3.2M in Q4 2021. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Sumitomo Life Insurance held 1,246 shares of Idexx Laboratories worth $656K as of Q2 2026.
  • Sumitomo Life Insurance sold 34 Idexx Laboratories shares in Q2 2026, an estimated $19.1K.
  • Idexx Laboratories made up 0.01% of Sumitomo Life Insurance's portfolio in Q2 2026, its #240 holding.
  • Sumitomo Life Insurance first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
  • Sumitomo Life Insurance's Idexx Laboratories position peaked at $3.2M in Q4 2021.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Sumitomo Life Insurance's 13F filing for Q2 2026, filed 12 Aug 2026.